3 research outputs found

    Endoscopic Submucosal Dissection for Recurrent or Residual Superficial Esophageal Cancer after Chemoradiotherapy: Two Cases

    Get PDF
    We report two cases of endoscopic submucosal dissection (ESD) for recurrent or residual esophageal squamous cell carcinoma (ESCC) lesions after chemoradiotherapy for advanced esophageal cancer. Case 1 involved a 64-year-old man who had previously undergone chemoradiotherapy for advanced ESCC and achieved a complete response (CR) for 22 months, until metachronous recurrent superficial ESCC was detected on follow-up esophagogastroduodenoscopy (EGD). We performed ESD and found no evidence of recurrence for 24 months. Case 2 involved a 59-year-old man who had previously undergone chemoradiotherapy for advanced ESCC. He responded favorably to treatment, and most of the tumor had disappeared on follow-up EGD 4 months later. However, there were two residual superficial esophageal lugol-voiding lesions. We performed ESD, and he had a CR for 32 months thereafter. ESD can be considered a viable treatment option for recurrent or residual superficial ESCC after chemoradiotherapy for advanced esophageal cancer.ope

    Transfusion-free Management for the Severe Anemia Developed after Nephrectomy

    Get PDF
    A 56-year-old woman with emphysematous pyelonephritis underwent an emergent left nephrectomy due to her religious creed. Postoperative hemoglobin level was decreased to 4.4 g/dL from preoperative value of 13.9 g/dL. The patient completely recovered without transfusion and was discharged on the 40th postoperative day without complication.ope

    Incidentally Found Chronic Neutrophilic Leukemia in a Patient with Rectal Cancer

    Get PDF
    ์ฆ๋ก€๋Š” ๊ฐ์—ผ ๋ฐ ์•…์„ฑ์ข…์–‘๊ณผ ๋™๋ฐ˜๋˜์–ด ๋ฐฑํ˜ˆ๋ณ‘์–‘ ๋ฐ˜์‘๊ณผ์˜ ๊ฐ๋ณ„์ด ์–ด๋ ค์› ๊ณ , ๋˜ํ•œ ์•…์„ฑ์ข…์–‘์˜ ์ „์ด์™€ ์œ ์‚ฌํ•˜๊ฒŒ ์ข…๊ดด๋ฅผ ํ˜•์„ฑํ•˜์—ฌ ๋”์šฑ ๊ฐ๋ณ„์ด ์–ด๋ ค์› ๋˜ CNL 1์˜ˆ๋ฅผ ๊ฒฝํ—˜ํ•˜์˜€๊ธฐ์— ๋ฌธํ—Œ๊ณ ์ฐฐ๊ณผ ํ•จ๊ป˜ ๋ณด๊ณ ํ•˜๋Š” ๋ฐ”์ด๋‹ค. Chronic neutrophilic leukemia (CNL) is a rare myeloproliferative neoplasm characterized by sustained neutrophilia, splenomegaly, and hypercellular bone marrow without Philadelphia chromosome. Diagnosis of CNL requires exclusion of identifiable causes of reactive neutrophilia, such as infection and tumors. Our patient presented with general weakness and weight loss. Computed tomography (CT) showed a mass in the distal rectum, which was confirmed to be an adenocarcinoma by colonoscopic biopsy. Positron emission tomography-CT showed multiple liver, bone, and lymph node metastases. Liver and lymph node biopsies revealed neutrophilic infiltration with no evidence of adenocarcinoma. The pathological findings of the bone marrow were compatible with CNL. Cytogenetic analysis revealed a normal karyotype, and molecular analysis was negative for BCR/ABL. Here, we present a 73 year-old man diagnosed with concurrent CNL and rectal cancer.ope
    corecore